Angelos M. Stergiou - Mar 12, 2020 Form 4/A - Amendment Insider Report for SELLAS Life Sciences Group, Inc. (SLS)

Role
President and CEO, Director
Signature
/s/ Angelos M. Stergiou
Stock symbol
SLS
Transactions as of
Mar 12, 2020
Transactions value $
$0
Form type
4/A - Amendment
Date filed
12/3/2021, 04:04 PM
Date Of Original Report
Mar 16, 2020
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SLS Common Stock 104K Mar 12, 2020 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amended Form 4/A is being filed to correct a mathematical error in Column 5 of the original Form 4 filed on March 16, 2020 regarding the amount of securities beneficially owned by the Reporting Person following the transaction. As a result of the mathematical error in Column 5 of the original Form 4 filed on March 16, 2020, Column 5 of the Form 4 filed on March 8, 2021 was incorrect and should have reflected an amount of 123,287.

Remarks:

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.